Insulin glargine Reference

Plain English

What it is

Insulin glargine, sold under brand names like Lantus and Toujeo, is a man-made, long-acting form of the hormone insulin. It works slowly and steadily in the background to help keep blood sugar under control. It is a prescription medicine approved by the FDA for people with type 1 or type 2 diabetes.

What people use it for

Doctors prescribe it as a steady, around-the-clock 'background' insulin for adults and children who have diabetes. The goal is to keep blood sugar from running too high over the course of the day and night.

What the science shows

It is a well-established, FDA-approved insulin, and its drug label states it improves blood sugar control in people with diabetes. pepSmart treats it as a real prescription medicine, not a research compound, and surfaces only label-reference information for it.

The catch

The main danger is blood sugar dropping too low. If the amount is measured wrong, blood sugar can crash, which can cause seizures and can be life-threatening or even fatal. This is a prescription medicine for diabetes that has to be managed by a doctor. It is not a fat-loss or performance tool, and using it without medical care is extremely dangerous.

Reference summary

Insulin glargine is a label-verified long-acting basal insulin analog. pepSmart surfaces label-reference content only.

Regulatory and posture

Categories

Hormonal, Metabolic

Aliases

Lantus, Toujeo, Long-acting basal insulin analog

Evidence posture

human - Prescription basal insulin. Severe hypoglycemia risk - incorrect dosing can be fatal. Not a research compound. Clinician-directed individualized titration is the only safe use.

Regulatory status

FDA-approved prescription medication (Lantus, Toujeo). Indicated as basal insulin therapy in type 1 and type 2 diabetes. Prescription-only.

Content review status

label verified

Related tools

• Injection-site rotation overview - Public overview of the Pro site-rotation planner.